The pro-Palestine student was arrested without due process for exercising his right to free speech. He will not be the last.

WWE RAW General Manager Adam Pearce announced a massive title match for next Monday's episode in London. Ex-WWE star Matthew Rehwoldt recently claimed the scheduled square-off would lead to a ...

NFL insider Adam Schefter is a busy man. With the new NFL season kicking off this week, Schefter is attempting to keep up with the trade market and free agency period, as well as which stars will be ...

The insider is rarely surprised by the news he reports because his sources hint that these moves are coming. Still, Schefter ...

The Sandler family have been involved in several of Adam Sandler's recent projects, including the 2023 animated film "Leo" and the 2023 comedy film "You Are So Not Invited to My Bat Mitzvah." ...

Jeff Lebby is a head coach who knows how to mix things up on offense. He can put the runners and throwers and catchers in positions, but Mississippi State also needs some tough players to block ...

Matthew Chapman is a video game designer who attended Rensselaer Polytechnic Institute and lives in San Marcos, Texas. Before joining Raw Story, he wrote for Shareblue and AlterNet, specializing ...

Rapid Enrollment and Dosing of First Patients in PRECISE-AD Trial Underscores the Unmet Need for Better Treatment Options for Alzheimer’s Disease PRECISE-AD Six Month Interim Results Expected in ...

Please use Chrome browser for a more accessible video player ...

While there have been plenty of topics of discussion throughout the year, one topic commissioner Adam Silver frequently ... league's All-Star Game format in recent years. The format this year ...

today announced financial results and recent corporate highlights for the full-year ended December 31, 2024. Lindsay A. Rosenwald, M.D., Fortress’ Chairman, President and Chief Executive Officer ...

"2024 was a transformational year for ProMIS Neurosciences as we reached a major milestone with the initiation of our 100-patient Phase 1b clinical trial for PMN310, our lead antibody candidate ...